Inotiv, inc. shareholders approve acquisition of envigo

West lafayette, ind., nov. 04, 2021 (globe newswire) -- inotiv, inc. (nasdaq: notv) (the “company”, “we”, “our” or “inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today announced that, at a special meeting of shareholders (the “special meeting”) held today, inotiv shareholders approved, among other matters, an increase in the company's authorized shares and the issuance of inotiv common shares to the stockholders and option holders of envigo rms holding corp. (“envigo”) in connection with the acquisition of envigo by merger of envigo with a newly formed, wholly owned subsidiary of the company. approval of these matters by the inotiv shareholders was a condition to the closing of the acquisition.
NOTV Ratings Summary
NOTV Quant Ranking